ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process
- PMID: 36406781
- PMCID: PMC9667481
- DOI: 10.3389/ti.2022.10915
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process
Abstract
The European Society for Organ Transplantation (ESOT) has created a platform for the development of rigorous and regularly updated evidence based guidelines for clinical practice in the transplantation field. A dedicated Guideline Taskforce, including ESOT-council members, a representative from the Centre for Evidence in Transplantation, editors of the journal Transplant International has developed transparent procedures to guide the development of guidelines, recommendations, and consensus statements. During ESOT's first Consensus Conference in November 2022, leading experts will present in-depth evidence based reviews of nine themes and will propose recommendations aimed at reaching a consensus after public discussion and assessment by an independent jury. All recommendations and consensus statements produced for the nine selected topics will be published including the entire evidence-based consensus-finding process. An extensive literature review of each topic was conducted to provide final evidence and/or expert opinion.
Keywords: consensus conference; guidelines; methodology; organ transplantation; platform.
Copyright © 2022 Cillo, Weissenbacher, Pengel, Jochmans, Roppolo, Amarelli, Belli, Berenguer, De Vries, Ferrer, Friedewald, Furian, Greenwood, Monbaliu, Nadalin, Neyrinck, Strazzabosco, Toso, Zaza, Thuraisingham, Berney, Potena, Montserrat and Selzner.
Conflict of interest statement
IJ received speaker fees from XVIVO perfusion paid to her institution. IJ is an ESOT Councilor for which she receives no reimbursement. JFe is recipient of a grant supported by Instituto de Salud Carlos III (ISCIII) through the project “PI18/00161 (Optimization of pancreas transplant graft: A multicentric study of histo-morphological and functional characteristics of unaccepted organs.)” and co-funded by the European Union. AdV received in the past speaker and consultation fees from Astellas, Chiesi, Hansa, Novartis, Sandoz, CSL Behring all of which paid to his institution. AdV is chair of the Dutch Kidney Advisory Committee (Landelijk Overleg NierTransplantatie LONT) for which he receives no reimbursement. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Institute of Medicine (US) Committee to Improve the National Institutes of Health Consensus Development Program. Consensus Development at the NIH: Improving the Program. Washington (DC): National Academies Press US; (1990). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical